1h Free Analyst Time
The pain management devices market is forecasted to grow by USD 3.11 billion during 2023-2028, accelerating at a CAGR of 9.45% during the forecast period. The report on the pain management devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of chronic diseases among geriatric population, growing demand for drug-free therapy, and increasing number of initiatives and improvements in healthcare industry.
The pain management devices market is segmented as below:
By Application
- Neuropathic pain
- Musculoskeletal disorder
- Cancer
- Facial and migraine
- Others
By Product
- Neurostimulation devices
- Infusion pumps
- Ablation devices
By Geographical Landscape
- North America
- Asia
- Europe
- Rest of World (ROW)
The report on the pain management devices market covers the following areas:
- Pain management devices market sizing
- Pain management devices market forecast
- Pain management devices market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Market Segmentation by Product
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global pain management devices market: Abbott Laboratories, AtriCure Inc., Avanos Medical Inc., B.Braun SE, Baxter International Inc., Becton Dickinson and Co., Boston Scientific Corp., DJO Global Inc., ICU Medical Inc., InfuTronix, Johnson and Johnson Services Inc., Kimberly Clark Corp., Medtronic Plc, Micrel Medical Devices SA, Moog Inc., Nevro Corp., OMRON Corp., Pfizer Inc., Stryker Corp., and Theragen Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is technological advances in ablation devices."
According to the report, one of the major drivers for this market is the increasing prevalence of chronic diseases among geriatric population.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- AtriCure Inc.
- Avanos Medical Inc.
- B.Braun SE
- Baxter International Inc.
- Becton Dickinson and Co.
- Boston Scientific Corp.
- DJO Global Inc.
- ICU Medical Inc.
- InfuTronix
- Johnson and Johnson Services Inc.
- Kimberly Clark Corp.
- Medtronic Plc
- Micrel Medical Devices SA
- Moog Inc.
- Nevro Corp.
- OMRON Corp.
- Pfizer Inc.
- Stryker Corp.
- Theragen Inc.
